2022 - Research.com Best Female Scientist Award
2017 - Fellow of the American Academy of Arts and Sciences
Her primary areas of investigation include Molecular biology, RNA interference, Genetic enhancement, Gene silencing and Genetics. Her Molecular biology research includes elements of Transgene, Viral vector, Recombinant DNA, Transduction and In vivo. The concepts of her RNA interference study are interwoven with issues in Cancer research, Gene knockdown, Mutant, Huntington's disease and Cell biology.
Her research integrates issues of Lung transplantation, Clinical course, Bioinformatics, Immunology and Pathology in her study of Genetic enhancement. Her Gene silencing research includes themes of RNA, Small hairpin RNA, Small interfering RNA, RNA polymerase II and Transcription. Her work on microRNA, Allele and Gene as part of her general Genetics study is frequently connected to RNA polymerase III, thereby bridging the divide between different branches of science.
The scientist’s investigation covers issues in Molecular biology, Cell biology, Virology, Genetic enhancement and RNA interference. The Molecular biology study combines topics in areas such as Transgene, Recombinant DNA, Hypoxanthine-guanine phosphoribosyltransferase, Mutant and In vivo. Beverly L. Davidson focuses mostly in the field of Virology, narrowing it down to topics relating to Viral vector and, in certain cases, Adenoviridae.
Her Genetic enhancement research is multidisciplinary, incorporating perspectives in Immunology and Bioinformatics. Her RNA interference study combines topics in areas such as Small hairpin RNA, Gene silencing, microRNA and Huntington's disease. Gene silencing is a primary field of her research addressed under Genetics.
Her scientific interests lie mostly in Cell biology, Huntington's disease, RNA interference, Genetics and Gene. Her Cell biology study integrates concerns from other disciplines, such as Cell, Immunology, Receptor, Transduction and Spinocerebellar ataxia. Her work deals with themes such as Gene knockdown, Spinocerebellar Ataxia Type 1, microRNA, Gene silencing and Deep cerebellar nuclei, which intersect with RNA interference.
In her work, HEK 293 cells, Virus, Gene expression, Small molecule and Three prime untranslated region is strongly intertwined with Computational biology, which is a subfield of Gene. Her study in Huntingtin is interdisciplinary in nature, drawing from both mTORC1, Molecular biology and Trinucleotide repeat expansion. As a member of one scientific family, Beverly L. Davidson mostly works in the field of Genetic enhancement, focusing on Viral vector and, on occasion, Virology and Pathology.
Beverly L. Davidson mainly focuses on Genetics, Huntingtin, RNA interference, Mutant and Molecular biology. Her study in the field of Gene silencing, Untranslated region, Transcriptome and Gene is also linked to topics like Retrotransposon. Beverly L. Davidson has researched Gene silencing in several fields, including Ataxin 7 and microRNA.
She combines subjects such as Mutant protein and Spinocerebellar Ataxia Type 1 with her study of RNA interference. Her Mutant research focuses on Transgene and how it connects with Small interfering RNA. Her research investigates the connection between Viral vector and topics such as Electroretinography that intersect with problems in Genetic enhancement.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
RNA polymerase III transcribes human microRNAs
Glen M. Borchert;William P. Lanier;Beverly L. Davidson.
Nature Structural & Molecular Biology (2006)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar;Haoquan Wu;Jodi L. McBride;Kyeong Eun Jung.
siRNA-mediated gene silencing in vitro and in vivo
Haibin Xia;Qinwen Mao;Henry L Paulson;Beverly L Davidson.
Nature Biotechnology (2002)
Lysosomal storage diseases
Frances M Platt;Alessandra d'Azzo;Beverly L Davidson;Elizabeth F Neufeld.
Annual Review of Biochemistry (1991)
A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.
Beverly L. Davidson;Edward D. Allen;Karen F. Kozarsky;James M. Wilson.
Nature Genetics (1993)
Current prospects for RNA interference-based therapies
Beverly L. Davidson;Paul B. McCray.
Nature Reviews Genetics (2011)
Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
Beverly L. Davidson;Colleen S. Stein;Jason A. Heth;Inês Martins.
Proceedings of the National Academy of Sciences of the United States of America (2000)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.
Scott Q. Harper;Patrick D. Staber;Xiaohua He;Steven L. Eliason.
Proceedings of the National Academy of Sciences of the United States of America (2005)
RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
Haibin Xia;Qinwen Mao;Steven L Eliason;Scott Q Harper.
Nature Medicine (2004)
Superoxide Production in Vascular Smooth Muscle Contributes to Oxidative Stress and Impaired Relaxation in Atherosclerosis
Miller Fj;Gutterman Dd;Rios Cd;Heistad Dd.
Circulation Research (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: